Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals, 64564-64565 [2019-25400]
Download as PDF
<![CDATA[
64564
Federal Register / Vol. 84, No. 226 / Friday, November 22, 2019 / Notices
is notice that on October 4, 2019, S &
B Pharma, Inc., DBA Norac Pharma, 405
South Motor Avenue, Azusa, California
91702–3232 applied to be registered as
a bulk manufacturer of the following
basic classes of controlled substances:
Controlled substance
Drug code
Gamma Hydroxybutyric Acid ...................................................................................................................................
Telrahydrocannabinois .............................................................................................................................................
Amphetamine ...........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ....................................................................................................................................................
Methylphenidate .......................................................................................................................................................
Pentobarbital ............................................................................................................................................................
4-Anilino-N-phenethyl-4-piperidine (ANPP) .............................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacture
the listed controlled substances in bulk
for use in product development and for
commercial sales to its customers. In
reference to drug code 7360 (marihuana)
and 7370 (tetrahydrocannabinois), the
company plans to bulk manufacture
both as synthetic substances. No other
activity for these dug codes is
authorized for this registration.
Dated: November 5, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019–25402 Filed 11–21–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–549]
Importer of Controlled Substances
Application: Mylan Technologies Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before December 23, 2019. Such
persons may also file a written request
for a hearing on the application on or
before December 23, 2019.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
DATES:
In
accordance with 21 CFR 1301.34(a), this
is notice that on October 16, 2019,
Mylan Technologies Inc., 110 Lake
Street, Saint Albans, Vermont 054780
applied to be registered as an importer
of the following basic classes of
controlled substances:
Drug code
khammond on DSKJM1Z7X2PROD with NOTICES
DEPARTMENT OF JUSTICE
Dated: November 8, 2019.
William T. McDermott,
Assistant Administrator.
DATES:
[FR Doc. 2019–25405 Filed 11–21–19; 8:45 am]
BILLING CODE 4410–09–P
Jkt 250001
Drug Enforcement Administration
[Docket No. DEA–540]
Bulk Manufacturer of Controlled
Substances Application: Chattem
Chemicals
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before January 21, 2020.
PO 00000
Frm 00112
Fmt 4703
1724
9801
In
accordance with 21 CFR 1301.33(a), this
is notice that on May 17, 2019, Chattem
Chemicals, 3801 Saint Elmo Avenue,
Chattanooga, Tennessee 37409 applied
to be registered as a bulk manufacturer
of the following basic classes of
controlled substances:
SUPPLEMENTARY INFORMATION:
Drug code
Sfmt 4703
II
II
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152.
Gamma Hydroxybutyric Acid ...................................................................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
16:57 Nov 21, 2019
Schedule
ADDRESSES:
Controlled substance
VerDate Sep<11>2014
I
I
II
II
II
II
II
II
II
II
SUPPLEMENTARY INFORMATION:
Methylphenidate .......................................................................................................................................................
Fentanyl ...................................................................................................................................................................
ACTION:
7360
7370
1100
1105
1205
1724
2270
8333
9780
9801
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing must
be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for a
hearing should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/OALJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DPW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
Controlled substance
The company plans to import the
listed controlled substances in finished
dosage form (FDF) from foreign sources
for analytical testing and clinical trials
in which the foreign FDF will be
compared to the company’s own
domestically-manufactured FDF. This
analysis is required to allow the
company to export domestically
manufactured FDF to foreign markets.
Schedule
E:\FR\FM\22NON1.SGM
22NON1
2010
7360
7370
Schedule
I
I
I
64565
Federal Register / Vol. 84, No. 226 / Friday, November 22, 2019 / Notices
Controlled substance
Drug code
4-Methoxyamphetamine ..........................................................................................................................................
Dihydromorphine ......................................................................................................................................................
Amphetamine ...........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ....................................................................................................................................................
Methylphenidate .......................................................................................................................................................
Cocaine ....................................................................................................................................................................
Codeine ....................................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ...............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Hydrocodone ............................................................................................................................................................
Levorphanol .............................................................................................................................................................
Methadone ...............................................................................................................................................................
Methadone intermediate ..........................................................................................................................................
Morphine ..................................................................................................................................................................
Oripavine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Noroxymorphone .....................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacturer
the listed controlled substances in bulk
for distribution and sale to its
customers.
In reference to drug codes 7360
(marihuana) and 7370
(tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as synthetics. No other activities for
these drug codes are authorized for this
registration.
Dated: November 5, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019–25400 Filed 11–21–19; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
[OMB Number 1117–0053]
Agency Information Collection
Activities; Proposed eCollection
eComments Requested; Extension of a
Previously Approved Collection:
Leadership Engagement Survey
Department of Justice, Drug
Enforcement Administration.
ACTION: 30-Day notice.
AGENCY:
The Department of Justice
(DOJ), Drug Enforcement
Administration (DEA), will be
submitting the following information
collection request to the Office of
Management and Budget (OMB) for
review and approval in accordance with
the Paperwork Reduction Act of 1995.
The proposed information collection
was previously published in the Federal
Register allowing for a 60 day comment
period.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
16:57 Nov 21, 2019
Jkt 250001
Comments are encouraged and
will be accepted for 30 days until
December 23, 2019.
DATES:
If
you have additional comments
especially on the estimated public
burden or associated response time,
suggestions, or need a copy of the
proposed information collection
instrument with instructions or
additional information, please contact
Chiwoniso S. Gurira (Choni), Senior
Personnel Psychologist, Drug
Enforcement Administration, 8701
Morrissette Drive, Springfield, VA
22152. Written comments and/or
suggestions may also be directed to the
Office of Management and Budget,
Office of Information and Regulatory
Affairs, Attention Department of Justice
Desk Officer, Washington, DC 20530 or
send to OIRA_submission@omb.eop.gov.
FOR FURTHER INFORMATION CONTACT:
This
process is conducted in accordance with
5 CFR 1320.10. Written comments and
suggestions from the public and affected
agencies concerning the proposed
collection of information are
encouraged. Your comments should
address one or more of the following
four points:
—Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the Bureau of Justice
Statistics, including whether the
information will have practical utility;
—Evaluate the accuracy of the agency’s
estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
SUPPLEMENTARY INFORMATION:
PO 00000
Frm 00113
Fmt 4703
Sfmt 4703
7411
9145
1100
1105
1205
1724
9041
9050
9120
9143
9150
9180
9193
9220
9250
9254
9300
9330
9333
9652
9668
9780
9801
Schedule
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
—Evaluate whether and if so how the
quality, utility, and clarity of the
information to be collected can be
enhanced; and
—Minimize the burden of the collection
of information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms
of information technology, e.g.,
permitting electronic submission of
responses.
Overview of This Information
Collection
1. Type of Information Collection:
Extension of a previously approved
collection for which approval has
expired.
2. The Title of the Form/Collection:
Leadership Engagement Survey.
3. The agency form number, if any
and the applicable component of the
Department sponsoring the collection:
Online survey.
4. Affected public who will be asked
or required to respond, as well as a brief
abstract:
Primary: Drug Enforcement
Administration contractors and Task
Force Officers.
Other: None.
5. An estimate of the total number of
respondents and the amount of time
estimated for an average respondent to
respond: It is estimated that 5000
respondents will complete the survey in
approximately 20 minutes.
6. An estimate of the total public
burden (in hours) associated with the
collection: The estimated public burden
associated with this collection is 1667
hours. It is estimated that applicants
E:\FR\FM\22NON1.SGM
22NON1
]]>Agencies
[Federal Register Volume 84, Number 226 (Friday, November 22, 2019)]
[Notices]
[Pages 64564-64565]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-25400]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-540]
Bulk Manufacturer of Controlled Substances Application: Chattem
Chemicals
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before January 21, 2020.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DPW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
is notice that on May 17, 2019, Chattem Chemicals, 3801 Saint Elmo
Avenue, Chattanooga, Tennessee 37409 applied to be registered as a bulk
manufacturer of the following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid............... 2010 I
Marihuana............................... 7360 I
Tetrahydrocannabinols................... 7370 I
[[Page 64565]]
4-Methoxyamphetamine.................... 7411 I
Dihydromorphine......................... 9145 I
Amphetamine............................. 1100 II
Methamphetamine......................... 1105 II
Lisdexamfetamine........................ 1205 II
Methylphenidate......................... 1724 II
Cocaine................................. 9041 II
Codeine................................. 9050 II
Dihydrocodeine.......................... 9120 II
Oxycodone............................... 9143 II
Hydromorphone........................... 9150 II
Ecgonine................................ 9180 II
Hydrocodone............................. 9193 II
Levorphanol............................. 9220 II
Methadone............................... 9250 II
Methadone intermediate.................. 9254 II
Morphine................................ 9300 II
Oripavine............................... 9330 II
Thebaine................................ 9333 II
Oxymorphone............................. 9652 II
Noroxymorphone.......................... 9668 II
Tapentadol.............................. 9780 II
Fentanyl................................ 9801 II
------------------------------------------------------------------------
The company plans to manufacturer the listed controlled substances
in bulk for distribution and sale to its customers.
In reference to drug codes 7360 (marihuana) and 7370
(tetrahydrocannabinols), the company plans to bulk manufacture these
drugs as synthetics. No other activities for these drug codes are
authorized for this registration.
Dated: November 5, 2019.
William T. McDermott,
Assistant Administrator.
[FR Doc. 2019-25400 Filed 11-21-19; 8:45 am]
BILLING CODE 4410-09-P
